283 results on '"Gao, Yuan-Hong"'
Search Results
2. Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial
3. High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer
4. The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trial
5. Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery
6. A Genotype Signature for Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer
7. Regular aspirin intake and prognosis of TxN2-3M0 nasopharyngeal carcinoma: A cohort study based on propensity score matching
8. Survival outcomes of different neoadjuvant treatment regimens in patients with locally advanced rectal cancer and MRI‐detected extramural venous invasion
9. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy
10. Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome
11. Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection
12. Prognostic value of ubiquitin E2 UBE2W and its correlation with tumor-infiltrating immune cells in breast cancer
13. The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
14. Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1
15. Granitoids indicating moderate to high heat production associated with oceanic subduction system in the NE Tibetan Plateau
16. Dosimetric parameters predict radiation-induced choanal stenosis in patients with nasopharyngeal carcinoma
17. Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy
18. Effect of taxanes-based induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A large scale propensity-matched study
19. Neoadjuvant Chemotherapy with CAPOX versus Chemoradiation for Locally Advanced Rectal Cancer with Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial
20. The Safety of an MRI Simulation-guided Boost after Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer (SUNRISE): Interim Analysis of a Randomized Phase II Trial
21. Subduction‐related mafic to felsic magmatism in the Xiangpishan concentric calc‐alkaline complex, Northeast Tibetan Plateau
22. Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer
23. Neoadjuvant Sandwich Treatment With Oxaliplatin and Capecitabine Administered Prior to, Concurrently With, and Following Radiation Therapy in Locally Advanced Rectal Cancer: A Prospective Phase 2 Trial
24. Triassic granites in the West Qinling Orogen, China: implications for the Early Mesozoic tectonic evolution of the Paleo-Tethys ocean
25. Influences of KMnO4 on the syntheses and properties of CaWO4 thin films prepared by galvanic cell methods
26. Triassic granites in the West Qinling Orogen, China: implications for the Early Mesozoic tectonic evolution of the Paleo-Tethys ocean.
27. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
28. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using 18fluorine-2-deoxy-d-glucose positron emission tomography–computed tomography and serum carcinoembryonic antigen: a prospective study
29. The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
30. Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)
31. Additional file 3 of High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer
32. Additional file 2 of High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer
33. Additional file 1 of High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer
34. Additional file 1 of Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery
35. Subduction‐related mafic to felsic magmatism in the Xiangpishan concentric calc‐alkaline complex, Northeast Tibetan Plateau.
36. Tailored selection of the interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer: analysis based on the pathologic stage or chemoradiation response
37. Neoadjuvant chemoradiotherapy with or without Pd-1 antibody sintilimab for pMMR/MSS/MSI-L locally advanced rectal cancer: A randomized controlled study (cohort B).
38. A nomogram for predicting cancer specific survival (CSS) in patients with pathological T3N0M0 (pT3N0M0) rectal cancer.
39. SONCAR study: A prospective randomized controlled study on optimized neoadjuvant chemotherapy-oxaliplatin plus CRT in patients with locally advanced rectal cancer.
40. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China
41. Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0
42. Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer
43. Additional file 1 of Prognostic value of ubiquitin E2 UBE2W and its correlation with tumor-infiltrating immune cells in breast cancer
44. Additional file 1 of The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
45. Additional file 1 of Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection
46. Additional file 1 of The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy
47. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision
48. Can Quantified Pathologic Response Assessed as Residual Tumor Burden Be a Promising Staging System for Patients With Rectal Cancer Treated With Chemoradiation Followed by Surgery?
49. Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer
50. Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.